Caricamento...

Conditional Superagonist CTL Ligands for the Promotion of Tumor-Specific CTL responses

While it has been demonstrated that cytotoxic T lymphocytes (CTL) can be raised against tumor-associated self-antigens, achieving consistent and effective clinical responses has proven challenging. Superagonist altered peptide ligands (APL) can often elicit potent anti-tumor CTL responses where the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Abdul-Alim, C. Siddiq, Li, Yongqing, Yee, Cassian
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3313650/
https://ncbi.nlm.nih.gov/pubmed/20483791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.0900448
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !